This brand name is authorized in Austria, France, Netherlands
The drug TALOXA contains one active pharmaceutical ingredient (API):
|
1
Felbamate
UNII X72RBB02N8 - FELBAMATE
|
|
Felbamate is an antiepileptic. The mechanism by which felbamate exerts its anticonvulsant activity is unknown, but in animal test systems designed to detect anticonvulsant activity, felbamate has properties in common with other marketed anticonvulsants. Felbamate is not indicated as a first line antiepileptic treatment. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N03AX10 | Felbamate | N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AX Other antiepileptics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FR | Base de données publique des médicaments | Identifier(s): 60223278, 62313468 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 14003422 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 44172, 44180 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
